Events Partner Content The Pharma Forecasting Workshop - Fundamentals of Forecastin... J+D Interactive Pharma Forecasting Workshop
Events Partner Content The Pharma Forecasting Workshop - Fundamentals of Forecastin... The Fundamentals of Forecasting with J+D
Partner Content Partner Content J+D, Pharma Forecasting Experts Partner with Epiphany, Oncol... J+D have brought several innovations to market this year including Online Training, th
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
